
Highlights from the Sarepta Webinar Regarding Etiplersen and Additional Exon Skipping Programs for Duichenne Muscular Dystrophy.
This is a very brief summary of some of the key points from this morning’s webinar hosted by Sarepta and moderated by Chris Garabedian, CEO and Ed Kaye, CMO. CureDuchenne […]
